Professor Pierre Cochat, M.D., Ph.D. (President)
Head of Pediatric Nephrology, University Hospitals of Lyon (Hospices Civils de Lyon (CHU))
Professor Larry Greenbaum, M.D., Ph.D. (Vice-President)
Division Director, Department of Pediatrics, Division of Nephrology, Emory University School of Medicine and Children’s Healthcare of Atlanta (Atlanta, U.S.A.)
Professor Bertrand Knebelmann, M.D., Ph.D.
Head of Nephrology at APHP-Hôpital Necker, Paris
Professor Gema Ariceta, M.D., Ph.D.
Head of Pediatric Nephrology at Vall d’Hebron University Hospital (Barcelona, Spain)
Professor Elena Levtchenko, M.D., Ph.D.
Head of Pediatric Nephrology at UZ Leuven (University Hospitals Leuven) (Leuven, Belgium)
Since its founding in 2007, Advicenne has been dedicated to developing and commercializing innovative treatments that address unmet medical needs in the area of nephrology. Our lead drug candidate, ADV7103, is in late-stage clinical trials for two indications: distal renal tubular acidosis (dRTA) and cystinuria. Listed on both the Euronext Paris and Euronext Brussels stock exchanges, the company is headquartered in Nîmes, France.
© 2019 Advicenne